The role of vasoactive intestinal polypeptide (VIP) as a hypothalamic neurohormone
- 1 June 1983
- journal article
- review article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 6 (3) , 235-242
- https://doi.org/10.1007/bf03350614
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- The influence of vasoactive intestinal polypeptide and cholecystokinin of prolactin release in rat and human monolayer culturesLife Sciences, 1981
- Effects of vasoactive intestinal polypeptide (VIP) in human prolactin (PRL) secreting pituitary adenomasFEBS Letters, 1980
- Adenylate cyclase of rat pituitary glandFEBS Letters, 1979
- Effect of vasoactive intestinal polypertide on prolactin release in vitroLife Sciences, 1979
- Vasoactive intestinal polypeptide (VIP): distribution in normal human brain and in Huntington's diseaseBrain Research, 1979
- Vasoactive intestinal peptide (VIP) stimulates prolactin (PRL) release and cAMP production in a rat pituitary cell line (GH3/B6). Additive effects of VIP and TRH on PRL releaseFEBS Letters, 1979
- VIP activation of rat anterior pituitary adenylate cyclaseFEBS Letters, 1979
- Vasoactive intestinal polypeptide: Release into hypophyseal portal bloodLife Sciences, 1979
- VASOACTIVE-INTESTINAL-POLYPEPTIDE CONCENTRATIONS IN MEDIAN EMINENCE OF HYPOTHALAMUSThe Lancet, 1978
- Loss of Central Nervous System Component of Dopaminergic Inhibition of Prolactin Secretion in Patients with Prolactin-Secreting Pituitary TumorsJournal of Clinical Investigation, 1978